FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999925313> ?p ?o ?g. }

• W1999925313 endingPage "1165" @default.
• W1999925313 startingPage "1155" @default.
• W1999925313 abstract "The small, highly conserved vasoactive peptide urotensin II (UII) is upregulated in atherosclerosis. However, its effects in diabetes-associated atherosclerosis have not been assessed. Endothelial cells were grown in normal- and high-glucose (5 and 25 mmol/l) media with and without UII (10−8 mol/l) and/or the UII receptor antagonist, SB-657510 (10−8 mol/l). Apoe knockout (KO) mice with or without streptozotocin-induced diabetes were treated with or without SB-657510 (30 mg kg−1 day−1; n = 20 per group) and followed for 20 weeks. Carotid endarterectomy specimens from diabetic and non-diabetic humans were also evaluated. In high (but not normal) glucose medium, UII significantly increased CCL2 (encodes macrophage chemoattractant protein 1 [MCP-1]) gene expression (human aortic endothelial cells) and increased monocyte adhesion (HUVECs). UII receptor antagonism in diabetic Apoe KO mice significantly attenuated diabetes-associated atherosclerosis and aortic staining for MCP-1, F4/80 (macrophage marker), cyclooxygenase-2, nitrotyrosine and UII. UII staining was significantly increased in carotid endarterectomies from diabetic compared with non-diabetic individuals, as was staining for MCP-1. This is the first report to demonstrate that UII is increased in diabetes-associated atherosclerosis in humans and rodents. Diabetes-associated plaque development was attenuated by UII receptor antagonism in the experimental setting. Thus UII may represent a novel therapeutic target in the treatment of diabetes-associated atherosclerosis." @default.
• W1999925313 created "2016-06-24" @default.
• W1999925313 creator A5000561404 @default.
• W1999925313 creator A5020484741 @default.
• W1999925313 creator A5023883891 @default.
• W1999925313 creator A5030776630 @default.
• W1999925313 creator A5044801901 @default.
• W1999925313 creator A5047272032 @default.
• W1999925313 creator A5048460362 @default.
• W1999925313 creator A5053780357 @default.
• W1999925313 creator A5055294177 @default.
• W1999925313 creator A5056874367 @default.
• W1999925313 creator A5082708905 @default.
• W1999925313 creator A5083223367 @default.
• W1999925313 date "2013-01-24" @default.
• W1999925313 modified "2023-10-17" @default.
• W1999925313 title "Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes" @default.
• W1999925313 cites W1486256755 @default.
• W1999925313 cites W1563426264 @default.
• W1999925313 cites W1945272325 @default.
• W1999925313 cites W1974252618 @default.
• W1999925313 cites W1988702757 @default.
• W1999925313 cites W1993518928 @default.
• W1999925313 cites W2004944698 @default.
• W1999925313 cites W2011052392 @default.
• W1999925313 cites W2013260905 @default.
• W1999925313 cites W2021240007 @default.
• W1999925313 cites W2026181520 @default.
• W1999925313 cites W2027981391 @default.
• W1999925313 cites W2039704412 @default.
• W1999925313 cites W2047223322 @default.
• W1999925313 cites W2051124233 @default.
• W1999925313 cites W2061643046 @default.
• W1999925313 cites W2063146137 @default.
• W1999925313 cites W2063808488 @default.
• W1999925313 cites W2074692122 @default.
• W1999925313 cites W2087385175 @default.
• W1999925313 cites W2088264978 @default.
• W1999925313 cites W2098344946 @default.
• W1999925313 cites W2102718347 @default.
• W1999925313 cites W2102970261 @default.
• W1999925313 cites W2113892902 @default.
• W1999925313 cites W2114837676 @default.
• W1999925313 cites W2123476690 @default.
• W1999925313 cites W2127062309 @default.
• W1999925313 cites W2129902595 @default.
• W1999925313 cites W2139136350 @default.
• W1999925313 cites W2145070360 @default.
• W1999925313 cites W2146426188 @default.
• W1999925313 cites W2147582807 @default.
• W1999925313 cites W2152996717 @default.
• W1999925313 cites W2155292938 @default.
• W1999925313 cites W2157815513 @default.
• W1999925313 cites W2163505296 @default.
• W1999925313 cites W2164976283 @default.
• W1999925313 doi "https://doi.org/10.1007/s00125-013-2837-9" @default.
• W1999925313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23344731" @default.
• W1999925313 hasPublicationYear "2013" @default.
• W1999925313 type Work @default.
• W1999925313 sameAs 1999925313 @default.
• W1999925313 citedByCount "34" @default.
• W1999925313 countsByYear W19999253132013 @default.
• W1999925313 countsByYear W19999253132014 @default.
• W1999925313 countsByYear W19999253132015 @default.
• W1999925313 countsByYear W19999253132016 @default.
• W1999925313 countsByYear W19999253132017 @default.
• W1999925313 countsByYear W19999253132018 @default.
• W1999925313 countsByYear W19999253132019 @default.
• W1999925313 countsByYear W19999253132020 @default.
• W1999925313 countsByYear W19999253132021 @default.
• W1999925313 countsByYear W19999253132022 @default.
• W1999925313 crossrefType "journal-article" @default.
• W1999925313 hasAuthorship W1999925313A5000561404 @default.
• W1999925313 hasAuthorship W1999925313A5020484741 @default.
• W1999925313 hasAuthorship W1999925313A5023883891 @default.
• W1999925313 hasAuthorship W1999925313A5030776630 @default.
• W1999925313 hasAuthorship W1999925313A5044801901 @default.
• W1999925313 hasAuthorship W1999925313A5047272032 @default.
• W1999925313 hasAuthorship W1999925313A5048460362 @default.
• W1999925313 hasAuthorship W1999925313A5053780357 @default.
• W1999925313 hasAuthorship W1999925313A5055294177 @default.
• W1999925313 hasAuthorship W1999925313A5056874367 @default.
• W1999925313 hasAuthorship W1999925313A5082708905 @default.
• W1999925313 hasAuthorship W1999925313A5083223367 @default.
• W1999925313 hasBestOaLocation W19999253131 @default.
• W1999925313 hasConcept C126322002 @default.
• W1999925313 hasConcept C134018914 @default.
• W1999925313 hasConcept C170493617 @default.
• W1999925313 hasConcept C2779280383 @default.
• W1999925313 hasConcept C2779935178 @default.
• W1999925313 hasConcept C2780189551 @default.
• W1999925313 hasConcept C519581460 @default.
• W1999925313 hasConcept C555293320 @default.
• W1999925313 hasConcept C71924100 @default.
• W1999925313 hasConceptScore W1999925313C126322002 @default.
• W1999925313 hasConceptScore W1999925313C134018914 @default.
• W1999925313 hasConceptScore W1999925313C170493617 @default.
• W1999925313 hasConceptScore W1999925313C2779280383 @default.

• next